Curated Wealth Partners LLC lessened its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 99.1% in the third quarter, Holdings Channel reports. The firm owned 1,684 shares of the company’s stock after selling 180,389 shares during the quarter. Curated Wealth Partners LLC’s holdings in Elevance Health were worth $655,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the company. WealthCollab LLC lifted its position in shares of Elevance Health by 42.2% during the 1st quarter. WealthCollab LLC now owns 91 shares of the company’s stock worth $27,000 after buying an additional 27 shares during the last quarter. Kilter Group LLC acquired a new stake in Elevance Health in the second quarter valued at approximately $28,000. Main Street Group LTD acquired a new position in shares of Elevance Health during the first quarter worth $39,000. Elevation Wealth Partners LLC boosted its holdings in shares of Elevance Health by 600.0% during the 2nd quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares in the last quarter. Finally, Tacita Capital Inc acquired a new position in shares of Elevance Health in the second quarter valued at approximately $44,000. 89.24% of the stock is owned by institutional investors.
Elevance Health Trading Up 0.2%
Shares of Elevance Health stock opened at $429.13 on Friday. The stock has a fifty day moving average price of $403.50 and a 200-day moving average price of $385.61. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.52 and a quick ratio of 1.52. The firm has a market cap of $93.06 billion, a PE ratio of 14.57, a P/E/G ratio of 2.22 and a beta of 0.70. Elevance Health, Inc. has a 1 year low of $274.84 and a 1 year high of $436.24.
Elevance Health (NYSE:ELV – Get Free Report) last released its earnings results on Wednesday, July 15th. The company reported $7.45 earnings per share for the quarter, beating analysts’ consensus estimates of $6.21 by $1.24. Elevance Health had a net margin of 2.47% and a return on equity of 14.64%. The firm had revenue of $49.83 billion for the quarter, compared to analysts’ expectations of $48.88 billion. During the same period in the previous year, the company earned $8.84 earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis. Equities research analysts anticipate that Elevance Health, Inc. will post 27.22 EPS for the current year.
Analyst Ratings Changes
ELV has been the subject of several analyst reports. Leerink Partners raised their price target on shares of Elevance Health from $364.00 to $395.00 and gave the company a “market perform” rating in a research note on Friday, July 17th. Guggenheim raised their price target on shares of Elevance Health from $455.00 to $460.00 and gave the stock a “buy” rating in a report on Monday. TD Cowen upped their price target on shares of Elevance Health from $400.00 to $465.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Wall Street Zen cut Elevance Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Finally, Robert W. Baird lifted their price objective on shares of Elevance Health from $331.00 to $393.00 and gave the company a “neutral” rating in a research note on Thursday, July 16th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, Elevance Health presently has a consensus rating of “Moderate Buy” and an average price target of $441.71.
View Our Latest Analysis on ELV
About Elevance Health
Elevance Health, Inc (NYSE: ELV) is a health benefits and services company that provides health insurance, managed care and related healthcare solutions in the United States. Its offerings serve individuals, employers, government-sponsored programs and other organizations across commercial, Medicare and Medicaid markets.
The company operates a portfolio of health plans, including Blue Cross Blue Shield-affiliated plans in several states, as well as government-focused plans marketed under brands such as Wellpoint.
Read More
- Five stocks we like better than Elevance Health
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.
